These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 6496281
1. The role of Holter monitoring in patients with recurrent sustained ventricular tachycardia: an electrophysiologic correlation. Ezri MD, Huang SK, Denes P. Am Heart J; 1984 Nov; 108(5):1229-36. PubMed ID: 6496281 [Abstract] [Full Text] [Related]
6. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia. Platia EV, Estes M, Heine DL, Griffith LS, Garan H, Ruskin JN, Reid PR. Am J Cardiol; 1985 Apr 01; 55(8):956-62. PubMed ID: 3984883 [Abstract] [Full Text] [Related]
7. The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone. Veltri EP, Griffith LS, Platia EV, Guarnieri T, Reid PR. Circulation; 1986 Nov 01; 74(5):1054-60. PubMed ID: 3769165 [Abstract] [Full Text] [Related]
8. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone. Manolis AS, Uricchio F, Estes NA. Am J Cardiol; 1989 May 01; 63(15):1052-7. PubMed ID: 2705375 [Abstract] [Full Text] [Related]
10. Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction. The Encainide-Ventricular Tachycardia Study Group. Am J Cardiol; 1988 Sep 15; 62(9):571-5. PubMed ID: 3137797 [Abstract] [Full Text] [Related]
11. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy. Veltri EP, Reid PR, Platia EV, Griffith LS. J Am Coll Cardiol; 1985 Oct 15; 6(4):806-13. PubMed ID: 3928726 [Abstract] [Full Text] [Related]
13. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation. Reiffel JA. Am J Cardiol; 1996 Aug 29; 78(4A):34-40. PubMed ID: 8780327 [Abstract] [Full Text] [Related]
14. Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias? Kim SG, Seiden SW, Felder SD, Waspe LE, Fisher JD. N Engl J Med; 1986 Aug 07; 315(6):356-62. PubMed ID: 2426592 [Abstract] [Full Text] [Related]
15. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome. Bhandari AK, Hong R, Au P, McKay CR, Rahimtoola SH. Can J Cardiol; 1988 Mar 07; 4(2):80-4. PubMed ID: 3365601 [Abstract] [Full Text] [Related]
17. The usefulness of Holter monitoring in selecting pharmacologic therapy for patients with sustained monomorphic ventricular tachycardia: studies in patients in whom no effective pharmacologic therapy could be determined by electrophysiologic study. Niwano S, Furushima H, Taneda K, Abe A, Ohira K, Aizawa Y. Jpn Circ J; 1998 May 07; 62(5):347-52. PubMed ID: 9626902 [Abstract] [Full Text] [Related]
20. Reproducibility of drug efficacy predictions by Holter monitoring in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. ESVEM Investigators. Reiter MJ, Karagounis LA, Mann DE, Reiffel JA, Hahn E, Hartz V. Am J Cardiol; 1997 Feb 01; 79(3):315-22. PubMed ID: 9036751 [Abstract] [Full Text] [Related] Page: [Next] [New Search]